Previous Close | 280.13 |
Open | 286.04 |
Bid | 0.00 x 1200 |
Ask | 0.00 x 3000 |
Day's Range | 284.05 - 294.33 |
52 Week Range | 261.59 - 473.50 |
Volume | |
Avg. Volume | 210,424 |
Market Cap | 8.108B |
Beta (5Y Monthly) | 0.88 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
ATNI, ABR and BIO have been added to the Zacks Rank #5 (Strong Sell) List on April 19, 2023.
The ongoing weakness in the biopharma end markets and tightening of sanctions against Russia is likely to have hurt Bio-Rad's (BIO) first-quarter 2024 growth.
Investing in stocks inevitably means buying into some companies that perform poorly. Long term Bio-Rad Laboratories...